The Next-Generation Copy Number Alteration (NG-CNA) assay can analyze small amounts of material to estimate metastatic risk, reports The Journal of Molecular Diagnostics ELSEVIER Philadelphia, December 12, 2018 – For men newly diagnosed with prostate cancer or patients previously treated, the risk of metastasis is a crucial determinant of whether to choose conservative management or...
Tag: <span>Cancer patients</span>
Post
Drug sensitivity and resistance testing could make ‘right to try’ a real thing
The contentious “right to try” bill that President Trump signed into law to help terminally ill patients get access to treatments that might — I emphasize the “might” — cure them or prolong their lives is more wishful thinking that it is a reality. Human HeLa cells in culture. Recent advances in drug sensitivity and resistance testing suggest that it’s worth...